PET scan in the therapeutic strategy

被引：4

作者：

Haioun, C ^{[1
]}

Itti, E ^{[1
]}

Rahmouni, A ^{[1
]}

Meignan, M ^{[1
]}

Reyes, F ^{[1
]}

机构：

[1] Hop Henri Mondor, F-94010 Creteil, France

来源：

HEMATOLOGY JOURNAL | 2004年 / 5卷

关键词：

D O I：

10.1038/sj.thj.6200442

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

收藏

页码：S149 / S153

页数：5

相关论文

共 21 条

[1]

Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation [J].

Becherer, A ;

Mitterbauer, M ;

Jaeger, U ;

Kalhs, P ;

Greinix, HT ;

Karanikas, G ;

Pötzi, C ;

Raderer, M ;

Dudczak, R ;

Kletter, K .

LEUKEMIA, 2002, 16 (02) :260-267

[2]

Blay JY, 1998, BLOOD, V92, P3562

[3]

Buchmann I, 2001, CANCER, V91, P889

[4]

Non-Hodgkin's lymphoma - Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma [J].

Cremerius, U ;

Fabry, U ;

Wildberger, JE ;

Zimny, M ;

Reinartz, P ;

Nowak, B ;

Schaefer, W ;

Buell, U ;

Osieka, R .

BONE MARROW TRANSPLANTATION, 2002, 30 (02) :103-111

[5]

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma:: Final analysis of the prospective LNH87-2 protocol -: A Groupe d'Etude des Lymphomes de l'Adulte Study [J].

Haioun, C ;

Lepage, E ;

Gisselbrecht, C ;

Salles, G ;

Coiffier, B ;

Brice, P ;

Bosly, A ;

Morel, P ;

Nouvel, C ;

Tilly, H ;

Lederlin, P ;

Sebban, C ;

Brière, J ;

Gaulard, P ;

Reyes, F .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :3025-3030

[6]

Haioun C., 2003, P AN M AM SOC CLIN, V22, P565

[7]

Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy [J].

Janicek, M ;

Kaplan, W ;

Neuberg, D ;

Canellos, GP ;

Shulman, LN ;

Shipp, MA .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1631-1637

[8]

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging [J].

Jerusalem, G ;

Beguin, Y ;

Fassotte, MF ;

Najjar, F ;

Paulus, P ;

Rigo, P ;

Fillet, G .

BLOOD, 1999, 94 (02) :429-433

[9]

Jerusalem G, 2000, HAEMATOLOGICA, V85, P613

[10]

Jerusalem G, 2001, HAEMATOLOGICA, V86, P266